Posted by neuralbudhist on December 22, 2009, at 19:40:53
In reply to Re: On a positive note, posted by willey on December 22, 2009, at 15:42:44
Yes I agree with what you said but please remember that glycine is part of a group of antipsychotics in Phase II FDA controlled study worldwide called the NMDA receptor modulates. Like any board people should not take medical advice from here regardless but glycine is in standard clinical study for that group of antipsychotics. There is much promising research. The same would not be true of the other compounds you mentioned. My specific recovery has been documented throughout multiple provider agencies. That doesn't mean other people will find the same results nor should they attempt to self medicate. Regardless such this class of antipsychotics is in standard psychiatric clinical study. I already posted this link:
http://www.psychiatrictimes.com/display/article/10168/1357569?verify=0
Which is from a highly reputable psychiatric journal. As well, this class of antipsychotics has other medications that unlike glycine have shown efficacy as primary antipsychotics:
http://www.nytimes.com/2007/09/03/business/03drug.html?_r=1
As well you can find out more where glycine is being researched:
http://ajp.psychiatryonline.org/cgi/content/full/164/10/1593?ck=nck
The fact that a compound that is in Phase II FDA study is available over the shelves shows exactly how under regulated natural remedies and compounds are. I agree that like on any site we should not make treatment reccomendations. I would state conclusively that my recovery from schizoaffective disorder with glycine has been clinically noted and that this class of antipsychotics is showing much promise in standard psychiatric research and that discussing the research into this new and promising class of antipsychotics is worthwhile. BTW the specifics of my recovery from schizoaffective disorder with glycine and the identification and treatment of the 3 as until now unknown neuropsychiatric aspects of tardive was published in a consumer mental health newsletter that is monitored by a standard reseach psychiatrist and was pre approved by my psychopharmocologist as well. However because it has my full name I would not print it here. However, since that article is of course in the public domain I will quote from it "testimony was presented as regarding my recovery with glycine as a novel antipsychotic agent 'as good as on any FDA approved antipsychotics or better' to quote my psychopharmocologist at the NARSAD Healthy Minds Across America Forum". It should be noted I am the first person to respond to glycine in regards to positive symptoms. However, the other NMDA receptor modulates in study are effective on all symptoms not just as adjunct antipsychotics. The information as regards this class of antipsychotics I posted is clinically accurate (coming from researchers, not myself) but as they are in Phase II FDA study it will take many further studies to understand them.
poster:neuralbudhist
thread:930347
URL: http://www.dr-bob.org/babble/alter/20091202/msgs/930397.html